Carbohydrate supplementation and cycling performance within different intensity domains
Summary
We are conducting a research study examining how carbohydrate supplementation and menstrual cycle impact performance in different exercise intensities. In a total of 10 visits (males) or 19 visits (females), you will perform cycling while drinking carbohydrate beverages and receiving muscle stimulations (non-invasive and painless) to measure your fatigue. The visits will involve continuous and maximal exercises.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 45
Accepts healthy participants: Yes
Inclusion criteria:
- you are either male or female (females who participate can either take oral contraceptives or have no birth control).
- you are between 18 and 45 years old.
- you are trained or recreationally active and doing aerobic exercise 4 days/week.
- you are able to cycle for 3 hours.
Exclusion criteria:
- you are obese (BMI >30 kg/m^2)
- you are a smoker
- you are allergic to alcohol used to disinfect the skin
- you are allergy to Splenda, Crystal Light, maltodextrin, or fructose.
- you have skin lesions, scarring, redness, infection, or edema on the arms.
- you are pregnant or attempting to conceive.
- you have metabolic, cardiovascular, or pulmonary diseases.
- you have orthopedic issues that limit exercise capacity.
- you are following a low carbohydrate (<1800 kcal/d) or Keto dieting.
- you are taking medication or are under any therapy that might affect cardiovascular and/or neuromuscular responses to exercise.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Pablo Fleitas Paniagua
Principal investigator:
Juan Murias
Clinical trial:
No
REB-ID:
REB22-0573